期刊文献+

肾癌HSP70-PC体外诱导DC成熟激活特异性抗肿瘤免疫的作用 被引量:7

HSP70-PC derived from renal carcinoma cells induces dendritic cell maturation and special antitumor immunity
下载PDF
导出
摘要 目的研究肾癌细胞株中纯化的HSP70-PC体外诱导DC成熟及激活特异性抗肿瘤免疫的作用。方法采用亲和层析及离子交换层析法纯化肾癌细胞HSP70-PC,体外致敏DC,流式细胞仪检测DC表型变化,用DC体外诱导CTL产生,MTT法比较其对不同肿瘤细胞的杀伤活性。结果HSP70-PC和TNF-α均能使DC高表达分化相关抗原CD1a、CD83、HLA-DR,肾癌细胞中纯化的HSP70-PC致敏的DC体外诱导的CTL对肾癌细胞有较高的杀伤活性。结论肾癌细胞中纯化的HSP70-PC能有效地诱导DC成熟,并使其具有活化针对肾癌细胞的特异性CTL的能力。 [Objective] To investigate HSP70-PC derived from renal carcinoma ceils induces dendritic cell maturation and special antitumor immunity. [Methods] Purify HSP70-PC from renal carcinoma ceils by affinity chromatography and ion-exchange chromatography. DCs pulsed with the HSP70-PC were detected the phenotypes by flow cytometry. The cytotoxity of CTLs activated by the DCs against the different cancers cells were evaluated by MTT method. [Results] Both the HSP70-PC and TNF-α could induce DC high expression of CDla, CD83, HLA-DR, but the DCs induced by the HSP70-PC derived from renal carcinoma ceils made the CTLs activated by it had the higher cytotoxity against the renal carcinoma ceils than the other cancer cells. [Conclusion] The HSP70-PC derived from renal carcinoma cells can effectively induce DC maturation and make it possess the ability of activating the special CTLs against renal carcinoma cells.
出处 《中国医学工程》 2006年第6期561-563,566,共4页 China Medical Engineering
关键词 树突状细胞 热休克蛋白70 肾癌 dendritic cell heat shock protein70 renal carcinoma
  • 相关文献

参考文献3

二级参考文献24

  • 1PAPP E, NARDAI G, SOTI C. et al. Molecular chaperones, stress proteins and redox homeostasis[J]. Biofactors, 2003, 17: 249-257.
  • 2HOOS A, LEVEY DL. Vaccination with heal shock protein-peptide complexes: from basic science to clinical applications[J]. Expert Rev Vaccines, 2003, 2(3): 369-379.
  • 3PENG P, MENORET A, SRIVASTAVA PK. Purification of immunogenic heat shock protein 70-peptide complexes hy ADP-affinity chromatography[J]. J Immunol Methods, 1997, 204: 13-31.
  • 4TAMURA Y, PENG P, LIU K, et al. Immunotherapy of tumors with autolagous tumor-derived heat shock protein preparations[J]. Science, 1997, 278: 117-120.
  • 5PARMIANI G, TESTORI A, MAIO M, et al. Heat shock proteins and their use as, anticancer vaccines[J]. Clin Cancer Res, 2004, 10(24): 8142-81466.
  • 6CASTELLI C, RIVOLTINI L, RINI F, et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer[J]. Cancer Immunol Immunother, 2004, 53(3): 227-233.
  • 7SRIVASTAVA PK, hnmunotherapy for human cancer using heat shock protein-peptide complexes[J]. Curr Oncol Rep, 2005, 7(2): 104-108.
  • 8UDONO H, SRIVASTAVA PK. Heat shock protein 70-associated peptides elieit specific cancer immunity [J]. J Exp Med, 1993, 178: 1391-1396.
  • 9Sai T,Milling SW,Mintz B.Freezing and thawing of bone marrow-derived murine dendritic cells with subsequent retention of immunophenotype and of antigen processing and presentation characteristics[].Journal of Immunological Methods.2002
  • 10Itano AA,McSorley SJ,Reinhardt RL,et al.Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity[].Immunity.2003

共引文献30

同被引文献50

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部